Genotwin Overview

  • Founded
  • 2020
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $200K
Latest Deal Amount

Genotwin General Information


Developer of clinical tools intended to monitor and manage the emergence and spread of pathogens. The company's platform consists of medical professionals, public health officials and researchers with powerful testing insights to diagnose, monitor and precision-treat pathogens and pathogen-based cancers, provides a single tissue test to identify thousands of microbes, including pathogenic viruses, bacteria and fungi, it can characterize the complex multi-microbial environment, including communal bacteria, to infer health-associated microbiome signatures, enabling public health officials to address and control the emergence of novel pathogens at an early stage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Services
Primary Office
  • 38 Clarence Avenue
  • Bridgewater, MA 02324
  • United States
+1 (347) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genotwin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 15-Dec-2020 $200K 00000 Completed Generating Revenue
To view Genotwin’s complete valuation and funding history, request access »

Genotwin Executive Team (2)

Name Title Board Seat Contact Info
Oliver Elliott Chief Executive Officer, President, Secretary & Board Member
Reuben Danzing Chief Financial Officer
To view Genotwin’s complete executive team members history, request access »

Genotwin Board Members (2)

Name Representing Role Since
Raul Rabadan Genotwin Board Member 000 0000
Seunghee Ham Genotwin Board Member 000 0000
To view Genotwin’s complete board members history, request access »